Tarsus Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tarsus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Tarsus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.42M, a 41.2% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $25.9M, a 43.7% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.8M, a 47.3% increase from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 59.2% increase from 2021.
  • Tarsus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.46M, a 908% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19.8M +$6.37M +47.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $13.5M +$5.01M +59.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $8.46M +$7.62M +908% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $839K +$821K +4561% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $18K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.